For full functionality, including active links, we recommend downloading the PDF. Certain interactive features may not operate within the embedded viewer.
Download this PDF file

 

Crossref Citations

1. Leishmaniavaccines: progress and problems
L. KEDZIERSKI, Y. ZHU, E. HANDMAN
Parasitology  vol: 133  issue: S2  first page: S87  year: 2006  
doi: 10.1017/S0031182006001831

2. An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major
Eva Iniguez, Nathaniel S. Schocker, Krishanthi Subramaniam, Susana Portillo, Alba L. Montoya, Waleed S. Al-Salem, Caresse L. Torres, Felipe Rodriguez, Otacilio C. Moreira, Alvaro Acosta-Serrano, Katja Michael, Igor C. Almeida, Rosa A. Maldonado, Paulo Filemon Pimenta
PLOS Neglected Tropical Diseases  vol: 11  issue: 10  first page: e0006039  year: 2017  
doi: 10.1371/journal.pntd.0006039

3. Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan
Roberta Olmo Pinheiro, Eduardo Fonseca Pinto, Herbert Leonel de Matos Guedes, Orlando Augusto Agrellos Filho, Katherine Antunes de Mattos, Elvira Maria Saraiva, Sergio Coutinho Furtado de Mendonça, Bartira Rossi-Bergmann
Vaccine  vol: 25  issue: 14  first page: 2716  year: 2007  
doi: 10.1016/j.vaccine.2006.05.093

4. Leishmania cell wall as a potent target for antiparasitic drugs. A focus on the glycoconjugates
Yari Cabezas, Laurent Legentil, Florence Robert-Gangneux, Franck Daligault, Sorya Belaz, Caroline Nugier-Chauvin, Sylvain Tranchimand, Charles Tellier, Jean-Pierre Gangneux, Vincent Ferrières
Organic & Biomolecular Chemistry  vol: 13  issue: 31  first page: 8393  year: 2015  
doi: 10.1039/C5OB00563A

5. Identifying vaccine targets for anti-leishmanial vaccine development
Shyam Sundar, Bhawana Singh
Expert Review of Vaccines  vol: 13  issue: 4  first page: 489  year: 2014  
doi: 10.1586/14760584.2014.894467

6. Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?
Claire-Lise Forestier, Qi Gao, Geert-Jan Boons
Frontiers in Cellular and Infection Microbiology  vol: 4  year: 2015  
doi: 10.3389/fcimb.2014.00193